appreciate your ongoing analysis and opinion. I'm wondering if anyone has any educated guesses on what (and when) might be the catalyst to really move the stock past the $1 minimum? successful completion of a study? FDA approval? acquisition by big pharma?
I never expected the stock to be sitting at 50 cents this far down the road.